AstraZeneca Expected to Post Higher Core Earnings, Revenue -- Earnings Preview
CORE EARNINGS PER SHARE: One of the Anglo-Swedish pharmaceutical major's preferred metrics, core EPS is expected to come in at $2.04 in the third quarter, according to a company-compiled consensus based on 18 analysts' estimates. For the same period last year, the company reported core EPS of $1.73.
2don MSN
Goldman Sachs estimated that each percentage-point cut to the corporate tax rate could boost S&P 500 earnings by slightly ...
Hosted on MSN11h
Cava Stock: Analysts Rush to Raise Price Targets After EarningsIts earnings per share improved 150% from the year-ago period to 15 cents. "Our third quarter results demonstrate the ...
Paysafe Limited (NYSE:PSFE) shares are trading lower on Wednesday. The company reported third-quarter adjusted earnings per ...
CyberArk Software (NASDAQ:CYBR) shares popped 8% in premarket trading Wednesday after the company reported much ...
EPS represents profitability per share by dividing net income ... A company can boost its EPS by increasing its earnings or reducing its share count through share buybacks, but a company ...
Analysts expect the Tulsa, Oklahoma-based company to report quarterly earnings at 81 cents per share, up from 69 cents ...
The next Nvidia earnings call is coming up on November 20. Kiplinger experts share news and analysis around the highly ...
Analysts estimate that bluebird bio will report an earnings per share (EPS) of $-0.37. Anticipation surrounds bluebird bio's announcement, with investors hoping to hear about both surpassing estimates ...
Heading into the report, analysts forecast Bloom Energy would earn $0.08 per share on sales of $382.2 million. In fact, Bloom ...
Hertz shares plunged as much as 12% on Tuesday after the company turned in its fourth quarterly loss in a row. The earnings ...
LUXEMBOURG — LUXEMBOURG — Spotify Technology SA (SPOT) on Tuesday reported third-quarter earnings of $329.7 million. On a per-share basis, the Luxembourg-based company said it had net income of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback